Clinical Trial Results: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection [Phase 2]

View source ↗

Summary

Phase 2 study assessing the safety and efficacy of BRII-835 and BRII-179 combo therapy for chronic hepatitis B; results completed and posted in 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Hepatitis B

Drugs mentioned

• BRII-179
• BRII-835

Snippet

Sponsor: Brii Biosciences Limited | Conditions: Hepatitis B, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2026-07-23